Aptorum Group Limited
Aptorum Group Limited (APM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APM · as of Jun 9, 2026
Key Statistics
Explore Aptorum Group Limited Data
apm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
apm competitorsAPM
AEON
BOLT
CING
CLRB
COCPStock Performance
Full HistoryAbout Aptorum Group Limited
Aptorum Group Limited operates as a biopharmaceutical firm, primarily engaged in the identification, development, and commercialization of medicinal treatments. Its core therapeutic efforts are direct…
what is aptorum group limited · apm stock overview · aptorum group limited company profile · who is aptorum group limited ceo · apm NASDAQ · aptorum group limited headquarters · aptorum group limited business segments
About Stock Overview & Key Data
Aptorum Group Limited (APM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 18, 2018. As of the latest trading session, APM stock price is $1.17, with a market capitalization of $7.4M. The stock has returned +2.63% over the past 12 months and +10.38% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Aptorum Group Limited stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aptorum Group Limited reported revenue of — and net income of -$1.4M. For detailed data — including Aptorum Group Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aptorum Group Limited (APM) stock price is $1.17. The stock is traded on NASDAQ under the ticker symbol APM. The 52-week range is $0.65 – $4.47.